{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:20:53Z","timestamp":1786980053237,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00381-018-3923-6","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T22:28:42Z","timestamp":1532903322000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy"],"prefix":"10.1007","volume":"35","author":[{"given":"Anna","family":"Mirska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Ku\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Okurowska-Zawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Dmitruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"3923_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-8749.2007.tb12609.x","volume":"49","author":"C Morris","year":"2007","unstructured":"Morris C (2007) Definition and classification of cerebral palsy: a historical perspective. Dev Med Child Neurol 49:3\u20137. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.2007.tb12609.x","journal-title":"Dev Med Child Neurol"},{"key":"3923_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00128072-200305010-00002","volume":"5","author":"LA Koman","year":"2003","unstructured":"Koman LA, Smith BP, Balkrishnan R (2003) Spasticity associated with cerebral palsy in children. Pediatr Drugs 5:11\u201323. \n                    https:\/\/doi.org\/10.2165\/00128072-200305010-00002","journal-title":"Pediatr Drugs"},{"key":"3923_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0966-6362(99)00054-5","volume":"11","author":"HK Graham","year":"2000","unstructured":"Graham HK, Aoki KR, Autti-R\u00e4m\u00f6 IG, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME Jr, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garc\u00eda Ruiz PJ, Wissel J (2000) Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11:67\u201379. \n                    https:\/\/doi.org\/10.1016\/S0966-6362(99)00054-5","journal-title":"Gait Posture"},{"key":"3923_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","volume":"14","author":"F Heinen","year":"2010","unstructured":"Heinen F, Desloovere K, Schoroeder AS et al (2010) The update European consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 14:45\u201366. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2009.09.005","journal-title":"Eur J Paediatr Neurol"},{"key":"3923_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2006.09.010","volume":"36","author":"VA Scholtes","year":"2007","unstructured":"Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Becher JG (2007) Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 36:30\u201339. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2006.09.010","journal-title":"Pediatr Neurol"},{"key":"3923_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpn.2006.08.006","volume":"10","author":"F Heinen","year":"2006","unstructured":"Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, di Rosa G, Kolanowski E, Kr\u00e4geloh-Mann I (2006) European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 10:215\u2013225. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2006.08.006","journal-title":"Eur J Paediatr Neurol"},{"key":"3923_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00381-007-0571-7","volume":"24","author":"Y Wang","year":"2008","unstructured":"Wang Y, Gao B (2008) A dose-response relationship research on botulinum toxin type a local intramuscular injections of lower extremity spasticity in children with cerebral palsy. Child Nerv Syst 24:545\u2013547. \n                    https:\/\/doi.org\/10.1007\/s00381-007-0571-7","journal-title":"Child Nerv Syst"},{"key":"3923_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/dmcn.13135","volume":"58","author":"A Kahraman","year":"2016","unstructured":"Kahraman A, Seyhan K, De\u011fer \u00dc, Kutlut\u00fcrk S, Mutlu A (2016) Should botulinum toxin a injections be repeated in children with cerebral palsy? A systematic review. Dev Med Child Neurol 58:910\u2013917. \n                    https:\/\/doi.org\/10.1111\/dmcn.13135","journal-title":"Dev Med Child Neurol"},{"key":"3923_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1469-8749.2008.02045.x","volume":"50","author":"PL Rosenbaum","year":"2008","unstructured":"Rosenbaum PL, Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJ (2008) Development of the Gross Motor Function Classification System for cerebral palsy. Dev Med Child Neurol 50:249\u2013253. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.2008.02045.x","journal-title":"Dev Med Child Neurol"},{"key":"3923_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1987","unstructured":"Bohannon RW, Smith M (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206\u2013207. \n                    https:\/\/doi.org\/10.1093\/ptj\/67.2.206","journal-title":"Phys Ther"},{"key":"3923_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1542\/peds.108.5.1062","volume":"108","author":"LA Koman","year":"2001","unstructured":"Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrari E, Garcia de Yebenes Prous J, Smith BP, Turkel C, Walcott JM, Molloy PT (2001) Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 108:1062\u20131071. \n                    https:\/\/doi.org\/10.1542\/peds.108.5.1062","journal-title":"Pediatrics"},{"key":"3923_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/BPB.0000000000000098","volume":"23","author":"A Mirska","year":"2014","unstructured":"Mirska A, Cybula K, Okurowska-Zawada B, Ku\u0142ak W, Dmitruk E, Okulczyk K, Kalinowska AK (2014) Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy. J Pediatr Orthop B 23:517\u2013522. \n                    https:\/\/doi.org\/10.1097\/BPB.0000000000000098","journal-title":"J Pediatr Orthop B"},{"key":"3923_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2340\/16501977-0418","volume":"41","author":"JH Lee","year":"2009","unstructured":"Lee JH, Sung IY, Yoo JY, Park EH, Park SR (2009) Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial. J Rehabil Med 41:740\u2013745. \n                    https:\/\/doi.org\/10.2340\/16501977-0418","journal-title":"J Rehabil Med"},{"key":"3923_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0887-8994(03)00269-8","volume":"29","author":"B Sarioglu","year":"2003","unstructured":"Sarioglu B, Serdaroglu G, Tutuncuoglu S, Ozer EA (2003) The use of botulinum toxin type a treatment in children with spasticity. Pediatr Neurol 29:299\u2013301. \n                    https:\/\/doi.org\/10.1016\/S0887-8994(03)00269-8","journal-title":"Pediatr Neurol"},{"key":"3923_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5114\/aoms.2014.46217","volume":"10","author":"H Colovic","year":"2014","unstructured":"Colovic H, Dimitrijevic L, Stankovic I, Nikolic D, Radovic-Janosevic D, Zivanovic D (2014) The effects of botulinum toxin type a on improvement and dynamic spastic equinus correction in children with cerebral palsy \u2013 preliminary. Arch Med Sci 10:979\u2013984. \n                    https:\/\/doi.org\/10.5114\/aoms.2014.46217","journal-title":"Arch Med Sci"},{"key":"3923_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.apmr.2006.08.342","volume":"87","author":"VA Scholtes","year":"2006","unstructured":"Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Becher JG (2006) The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil 87:1551\u20131558. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2006.08.342","journal-title":"Arch Phys Med Rehabil"},{"key":"3923_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1440-1754.1999.00330.x","volume":"35","author":"PJ Flett","year":"1999","unstructured":"Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK (1999) Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 35:71\u201377. \n                    https:\/\/doi.org\/10.1046\/j.1440-1754.1999.00330.x","journal-title":"J Paediatr Child Health"},{"key":"3923_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1590\/S0004-282X2009000100016","volume":"67","author":"CH Camargo","year":"2009","unstructured":"Camargo CH, Teive HA, Zonta M et al (2009) Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy. Arq Neuropsiquiatr 67:62\u201368. \n                    https:\/\/doi.org\/10.1590\/S0004-282X2009000100016","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"3923_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1590\/S1807-59322010000600009","volume":"65","author":"E Unlu","year":"2010","unstructured":"Unlu E, Cevikol A, Bel B, Gonen E, Celik O, Kose G (2010) Multilevel botulinum toxin type A as a treatment for spasticity in children with cerebral palsy: a retrospective study. Clinics 65(6):613\u2013619. \n                    https:\/\/doi.org\/10.1590\/S1807-59322010000600009","journal-title":"Clinics"},{"issue":"Suppl 5","key":"3923_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1468-1331.2001.00038.x","volume":"8","author":"SC Love","year":"2001","unstructured":"Love SC, Valentine JP, Blair EM, Price CJ, Cole JH, Chauvel PJ (2001) The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial. Eur J Neurol 8(Suppl 5):50\u201358","journal-title":"Eur J Neurol"},{"issue":"3","key":"3923_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1468-1331.2003.00582.x","volume":"10","author":"J S\u0142awek","year":"2003","unstructured":"S\u0142awek J, Klimont L (2003) Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results. Eur J Neurol 10(3):313\u2013317. \n                    https:\/\/doi.org\/10.1046\/j.1468-1331.2003.00582.x","journal-title":"Eur J Neurol"},{"key":"3923_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1469-8749.2003.tb00885.x","volume":"45","author":"M Bottos","year":"2003","unstructured":"Bottos M, Benedetti MG, Salucci P, Gasparroni V, Giannini S (2003) Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 45:758\u2013762. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.2003.tb00885.x","journal-title":"Dev Med Child Neurol"},{"key":"3923_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1469-8749.2008.03189.x","volume":"51","author":"K Tedroff","year":"2009","unstructured":"Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y (2009) Long-term effects of botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 51:120\u2013127. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.2008.03189.x","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 5","key":"3923_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1468-1331.2001.00044.x","volume":"8","author":"M Linder","year":"2001","unstructured":"Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, Berweck S, Korinthenberg R, Heinen F (2001) Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure. Eur J Neurol 8(Suppl 5):120\u2013126","journal-title":"Eur J Neurol"},{"key":"3923_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11832-007-0075-8","volume":"2","author":"A Fattal-Valevski","year":"2008","unstructured":"Fattal-Valevski A, Domenievitz D, Giladi N, Wientroub S, Hayek S (2008) Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study. J Child Orthop 2:29\u201335. \n                    https:\/\/doi.org\/10.1007\/s11832-007-0075-8","journal-title":"J Child Orthop"},{"key":"3923_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2006.08.003","volume":"35","author":"A Papavasiliou","year":"2006","unstructured":"Papavasiliou A, Rapidi CA, Filiopoulos C, Rizou C, Skouteli HN (2006) Evaluation of multimodal management of prematurity-related spasticity. Pediatr Neurol 35:400\u2013407. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2006.08.003","journal-title":"Pediatr Neurol"},{"key":"3923_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ridd.2017.07.002","volume":"68","author":"FA Read","year":"2017","unstructured":"Read FA, Boyd RN, Baber LA (2017) Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular botulinum toxin-A injections. Res Dev Disabil 68:35\u201341. \n                    https:\/\/doi.org\/10.1016\/j.ridd.2017.07.002","journal-title":"Res Dev Disabil"},{"key":"3923_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/toxins9080253","volume":"9","author":"BY Hong","year":"2017","unstructured":"Hong BY, Chang HJ, Lee SJ, Lee S, Park JH, Kwon JY (2017) Efficacy of repeated botulinum toxin type a injections for spastic equinus in children with cerebral palsy\u2014a secondary analysis of the randomized clinical trial. Toxins 9:253. \n                    https:\/\/doi.org\/10.3390\/toxins9080253","journal-title":"Toxins"},{"key":"3923_CR29","first-page":"408","volume":"6","author":"N Harries","year":"2004","unstructured":"Harries N, Kassirer M, Amichai T, Lahat E (2004) Changes over years in gross motor function of 3-8 year children with cerebral palsy: using the gross motor function measure (GMFM-88). Isr Med Assoc J 6:408\u2013411","journal-title":"Isr Med Assoc J"},{"key":"3923_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/jama.288.11.1357","volume":"288","author":"PL Rosenbaum","year":"2002","unstructured":"Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, Wood E, Bartlett DJ, Galuppi BE (2002) Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 288:1357\u20131363. \n                    https:\/\/doi.org\/10.1001\/jama.288.11.1357","journal-title":"JAMA"},{"key":"3923_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1017\/S001216220700014X.x","volume":"49","author":"K Desloovere","year":"2007","unstructured":"Desloovere K, Molenaers G, De Cat J et al (2007) Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol 49:56\u201361. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.2007.014xa.x","journal-title":"Dev Med Child Neurol"},{"key":"3923_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1590\/0004-282X20130061","volume":"71","author":"MB Zonta","year":"2013","unstructured":"Zonta MB, Bruck I, Puppi M, Muzzolon S, Neto AC, Santos LHC (2013) Effects early spasticity treatment on children with hemiplegic cerebral palsy: a preliminary study. Arq Neuropsiquiatr 71:453\u2013461. \n                    https:\/\/doi.org\/10.1590\/0004-282X20130061","journal-title":"Arq Neuropsiquiatr"},{"key":"3923_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/s-2007-973475","volume":"30","author":"J Wissel","year":"1999","unstructured":"Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, M\u00fcller J, Poewe W (1999) Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of \u201chigh-dose\u201d versus \u201clow-dose\u201d treatment. Neuropediatrics 30:120\u2013124. \n                    https:\/\/doi.org\/10.1055\/s-2007-973475","journal-title":"Neuropediatrics"},{"key":"3923_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1469-8749.1994.tb11864.x","volume":"30","author":"AP Cosgrove","year":"1994","unstructured":"Cosgrove AP, Corry IS, Graham HK (1994) Botulinum toxin in the management of the lower limb. Dev Med Child Neurol 30:386\u2013396. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.1994.tb11864.x","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl","key":"3923_CR35","first-page":"35","volume":"9","author":"AM Chutorian","year":"1994","unstructured":"Chutorian AM, Root L (1994) Management of spasticity in children with botulinum toxin A. Intl Paediatric 9(Suppl):35\u201343","journal-title":"Intl Paediatric"},{"key":"3923_CR36","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A Paiva de","year":"1999","unstructured":"de Paiva A, Muenier FA, Molgo J, Aoki KR, Dolly JO (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3220\u20133225. \n                    https:\/\/doi.org\/10.1073\/pnas.96.6.3200","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3923_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/S0012162299000493","volume":"41","author":"NW Eames","year":"1999","unstructured":"Eames NW, Baker R, Hill N, Graham K, Taylor T, Cosgrove A (1999) The effect of botulinum toxin A on gastrocnemius length and duration of response. Dev Med Child Neurol 41:226\u2013232. \n                    https:\/\/doi.org\/10.1111\/j.1469-8749.1999.tb00589.x","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 4","key":"3923_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-1331.1999.tb00037.x","volume":"6","author":"J Wissel","year":"1999","unstructured":"Wissel J, M\u00fcller J, Baldauf A, Ung SC, Ndayisaba JP, St\u00f6ckl B, Frischhut B, Haberfellner H, Poewe W (1999) Gait analysis to assess the effects of botulinum toxin type A treatment in cerebral palsy: an open-label study in ten children with equinus gait pattern. Eur J Neurol 6(Suppl 4):23\u201335. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.1999.tb00037.x","journal-title":"Eur J Neurol"},{"issue":"Suppl 2","key":"3923_CR39","first-page":"23","volume":"4","author":"I Autti-R\u00e4m\u00f6","year":"1997","unstructured":"Autti-R\u00e4m\u00f6 I, Larsen A, Peltonen J, Heinen F (1997) The use of botulinum toxin treatment in children with movement disorders. Eur J Neurol 4(Suppl 2):23\u201326","journal-title":"Eur J Neurol"},{"issue":"4","key":"3923_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/088307380201700407","volume":"17","author":"A Fattal-Valevski","year":"2002","unstructured":"Fattal-Valevski A, Giladi N, Domanievitz D, Zuk L, Masterman R, Harel S, Wientroub S, Hayek S (2002) Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol 17(4):272\u2013276. \n                    https:\/\/doi.org\/10.1177\/088307380201700407","journal-title":"J Child Neurol"},{"key":"3923_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/08830738050200080501","volume":"20","author":"E Fazzi","year":"2005","unstructured":"Fazzi E, Maraucci I, Torrieli S, Motta F, Lanzi G (2005) Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy. J Child Neurol 20:661\u2013666. \n                    https:\/\/doi.org\/10.1177\/08830738050200080501","journal-title":"J Child Neurol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-018-3923-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T18:10:09Z","timestamp":1566929409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-018-3923-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3923"],"URL":"https:\/\/doi.org\/10.1007\/s00381-018-3923-6","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Medical University of Bialystok, Poland. Informed consent was obtained from the parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}